Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/52043
Title: Apo(B)-dependent dyslipidemic phenotypes in type 1 diabetic patients
Authors: Wägner, Ana Marı́a 
Ordóñez-Llanos, Jordi
Hernández, Marta
Luis Sánchez-Quesada, Jose
Blanco-Vaca, Francisco
Rigla, Mercedes
de Leiva, Alberto
Pérez, Antonio
UNESCO Clasification: 32 Ciencias médicas
3205 Medicina interna
Keywords: Apolipoprotein (B)
Hyperapo(B)lipoproteinemia
Insulin-dependent diabetes mellitus
Diabetic dyslipidemia
Issue Date: 2001
Journal: European Journal of Internal Medicine 
Abstract: Background: The prevalence of apo(B)-dependent dyslipidemic phenotypes, which are associated with cardiovascular disease, is increased in normocholesterolemic type 2 diabetic patients. Our aim was to determine the impact of including apo(B) in the evaluation of normocholesterolemic type 1 diabetic patients. Methods: A total of 123 type 1 diabetic patients (47% male, age 36.6±12.5 years) were included. The apo(B) cut-off point (1.14 g/l) was obtained from a group of 53 normolipidemic control subjects of similar age and gender distribution; for low density lipoprotein cholesterol (LDLc), triglycerides, and high density lipoprotein cholesterol (HDLc), we used the cut-off points recommended by the National Cholesterol Education Program. LDLc was determined by ultracentrifugation or Friedewald’s equation, depending on triglyceride concentrations, and apo(B) by immunoturbidimetry. Results: A total of 113 (92%) type 1 diabetic patients were normocholesterolemic, and 13% of these were dyslipidemic. The frequency of hyperapo(B) was similar in normocholesterolemic patients and controls (6.2 vs. 9.4%, respectively). Diabetic patients with hyperapo(B) had poorer glycemic control, higher total cholesterol, triglycerides, and LDLc, and a lower HDLc and LDLc/apo(B) ratio. Conclusions: Unlike type 2 diabetes, type 1 diabetes is not associated with an increased prevalence of hyperapo(B)-dependent dyslipidemic phenotypes. Thus, only in patients with poor glycemic control who display other components of diabetic dyslipidemia, typical for type 2 diabetes, does determining apo(B) concentrations provide additional information in type 1 diabetes.
URI: http://hdl.handle.net/10553/52043
ISSN: 0953-6205
DOI: 10.1016/S0953-6205(01)00178-9
Source: European Journal of Internal Medicine[ISSN 0953-6205],v. 12(6), p. 496-502 (Diciembre 2001)
Appears in Collections:Artículos
Show full item record

SCOPUSTM   
Citations

1
checked on Dec 4, 2022

Page view(s)

18
checked on Jul 30, 2022

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.